Researchers have found in a new study that Laparoscopic radiofrequency ablation (RFA) and myomectomy produced significant and sustained improvements in uterine fibroid symptoms and health-related quality of life over 2 years. Although myomectomy showed slight advantages, the differences were not clinically significant. RFA may be an option for women seeking symptom relief while preserving the possibility of vaginal childbirth. The study was published in the Obstetrics and Gynecology journal by Antoinette A. and colleagues.

A robust comparison of the patient reported outcomes between these two procedures was performed using the data collected in the ULTRA (Uterine Leiomyoma Treatment with Radiofrequency Ablation) prospective cohort multicenter study carried out in both academic and community hospitals in the US.

The study included 401 pre-menopausal women (mean age 39.2 ± 6.9 years; 53% African American [n = 210]) with symptomatic uterine fibroids, and the patients opted for either laparoscopic RFA (n = 237) or myomectomy (n = 164). They were asked to complete validated questionnaires, such as the UFS-QOL (Uterine Fibroid Symptom and Health-related Quality of Life), at baseline and 6-month intervals up to 24 months after treatment. Propensity weighted repeated measures analysis was used to reduce potential biases.

Key findings:

  • Propensity-weighted modeling across the 401 study participants provided detailed quantitative metrics regarding symptom relief and quality-of-life trajectories over the 24-month observation period.
  • Among 401 enrolled women (237 RFA, 164 myomectomy), 386 provided follow-up measures; participants presented with a median of 2 leiomyomas (IQR 1–15) and severe baseline symptom burden (mean SSS score 61 ± 23; mean HRQOL score 41 ± 26).
  • Both cohorts demonstrated marked improvement; myomectomy achieved a slightly greater reduction in Symptom Severity Scale (SSS) scores compared to RFA (−33.0 vs. −27.7; mean difference −5.27, P = 0.028).
  • The myomectomy group demonstrated modestly greater improvements in overall HRQOL score compared to RFA (34.92 vs. 28.29; mean difference −6.62, P = 0.011).
  • The statistical differences observed between treatments remained below the predefined clinical thresholds required for minimal clinically important changes (10 points for SSS and 20 points for HRQOL).
  • Furthermore, while myomectomy showed minor early advantages at 6 months in functional domains like daily activities, personal control, and self-consciousness, these subtle differences diminished and were completely absent by 24 months.

In conclusion, laparoscopic RFA and myomectomy both result in considerable and lasting benefits in the management of symptoms associated with fibroids for two years. The findings in the study show that although myomectomy results in slight numerical increases in some subscales, the overall difference is too small to be clinically significant.

Reference:

Allen, A., Schembri, M., Parvataneni, R., Waetjen, L. E., Varon, S., Salamat-Saberi, N., Garza, H., Kho, K. A., Sobolewski, C. J., Hawkins, S., Williams, N., Tassone, S., & Jacoby, V. L. (2026). Effectiveness of Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas Compared With Myomectomy on Symptoms and Health-Related Quality of LifeObstetrics & Gynecology https://doi.org/10.1097/AOG.0000000000006432


Tags:    
Article Source : Obstetrics and Gynecology journal

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .